Menu
Back to Journals » Cancer Management and Research » Volume 5
Focal low-dose rate brachytherapy for the treatment of prostate cancer
Authors Tong WY, Cohen G, Yamada Y
Received 15 April 2013
Accepted for publication 19 June 2013
Published 13 September 2013 Volume 2013:5 Pages 315—325
DOI https://doi.org/10.2147/CMAR.S33056
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
William Y Tong, Gilad Cohen, Yoshiya Yamada
Memorial Sloan-Kettering Cancer Center, Department of Radiation Oncology, New York, NY, USA
Abstract: Whole-gland low-dose rate (LDR) brachytherapy has been a well-established modality of treating low-risk prostate cancer. Treatment in a focal manner has the advantages of reduced toxicity to surrounding organs. Focal treatment using LDR brachytherapy has been relatively unexplored, but it may offer advantages over other modalities that have established experiences with a focal approach. This is particularly true as prostate cancer is being detected at an earlier and more localized stage with the advent of better detection methods and newer imaging modalities.
Keywords: prostate cancer, focal, low dose rate, brachytherapy
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.